Bacteria survive many types of synthesis-blocking DNA lesion by inducing a number of proteins that enable their polymerases to synthesize past a lesion, albeit at the cost of an increased mutation rate. This process has now been convincingly achieved in vitro, opening the way to a fuller understanding of the mechanism.
Three decades of genetic studies (reviewed in [2] ) have elucidated the proteins that are essential for SOS mutagenesis, namely RecA, the single-strand binding protein Ssb, the RecA-generated UmuD cleavage product UmuD′ and UmuC. They have also provided strong circumstantial evidence that these proteins allow a complex containing all or part of DNA polymerase III holoenzyme to catalyse 'translesion synthesis' past non-instructional lesions in the template strand. The actual mechanism of translesion synthesis, however, remains cloaked in mystery. Reconstruction of SOS mutagenesis in vitro would be a major step in allowing models to be tested, and this has now been achieved by two groups [3, 4] .
The main problem in reconstituting SOS mutagenesis in vitro has been an inability to purify usable quantities of active UmuC, because of the protein's insolubility in water. An earlier partially successful attempt [5] used a denatured-renatured form of UmuC, which had relatively little activity. The problem has now been overcome in two different ways. Tang et al. [3] were able to purify UmuC directly as a complex with two molecules of UmuD′ (UmuD′ 2 C). Reuven et al. [4] purified both UmuD′ and UmuC as soluble proteins fused to a portion of the maltose binding protein (MBP), which could be released from UmuD′ but not from UmuC. Fortunately for them, the MBP-tagged UmuC proved to be biologically active and could be used in the reconstituted system.
Both groups used a primer-template substrate with an abasic site in the template as a model DNA lesion. It is known that polymerase III holoenzyme is almost completely unable to insert a base opposite the abasic site and continue synthesis. Addition of RecA, Ssb and UmuD′ 2 C (or UmuD′ plus MBP-tagged UmuC), together with ATP and the four deoxynucleotide triphosphates (dNTPs), allowed translesion synthesis and completion of the replication product. Absence of any one of RecA, Ssb or UmuD′ 2 C reduced the extent of translesion synthesis. In essence, therefore, both groups have achieved a practical reconstituted system. How then do the results impinge upon the speculative models of the mechanism of translesion synthesis that are currently in vogue?
When the first experiments implicating polymerase III holoenzyme in translesion synthesis were reported [6] , an inducible factor was postulated to enable polymerase III holoenzyme, when faced with a lesion in the template strand, to override its normal high specificity and insert a base opposite the lesion. The base was perhaps chosen at random, thus leading to base-pair substitution mutations. Subsequent work confirmed the involvement of polymerase III holoenzyme and revealed that the inducible factors are UmuC, UmuD′ and RecA. Not all translesion synthesis events are mutagenic, but in those that are, the process can be divided operationally into two steps: insertion of a base opposite the lesion (misincorporation), and bypass or elongation from the resulting 'mismatch'. Indirect genetic evidence points to polymerase III holoenzyme as being involved at least in the bypass step, and UmuC and UmuD′ as being involved in the bypass and not in the misincorporation step, but proof of this has been hard to come by. Convincing evidence as to how they carry out their roles is also lacking.
Reuven et al. [4] found that, in the absence of polymerase III holoenzyme, the remaining components of the reconstituted system carry out translesion synthesis to less than Dispatch R887 0.5% of the extent in the presence of polymerase III holoenzyme. Tang et al. [3] , in contrast, observed significant lesion bypass even in the absence of exogenous polymerase III holoenzyme. They cannot tell whether their UmuD′ 2 C has a low polymerase activity or whether an impurity is present, but the latter seems the most likely explanation given that Reuven et al. [4] purified their Umu proteins completely differently and found no polymerase activity. It might, of course, be argued that the MBP tag on the UmuC made by Reuven et al. [4] might have inactivated polymerase function. Whether or not UmuC has an intrinsic polymerase activity, it appears to be inessential for translesion synthesis.
A major conclusion of the paper by Reuven et al. [4] is that some translesion synthesis can be mediated by polymerase III holoenzyme in the absence of UmuD′ and UmuC, and that when it occurs the polynucleotide chain is elongated without insertion of any base opposite the abasic site, leading to a frameshift mutation. They argue that a major function of the Umu proteins is to convert potentially lethal frameshift mutations into the milder and more useful base-pair substitutions. Tang et al. [3] do not report frameshift mutations and had to use much higher concentrations of polymerase III holoenzyme to get any translesion synthesis in the absence of UmuD′ 2 C. Their substrate is, however, longer than that of Reuven et al. [4] , and examination of their gels suggests that they might not have had sufficient resolution to detect -1 frameshifts in the polymerase III holoenzyme lanes.
Even when polymerase III holoenzyme is acting on undamaged DNA in vitro it is prone to generate -1 frameshifts to a much greater extent than is observed in vivo [7] . So it may be that -1 frameshifts produced by polymerase III holoenzyme during translesion synthesis in the absence of Umu proteins are indeed real, but are they biologically relevant? Although most mutations are targeted base substitutions when Umu proteins are present, it is clear that -1 frameshifts are still produced as a minority product. This is true, not only in vitro, but also in vivo when damaged DNA is transformed into SOS-induced bacteria. This was shown not only by Reuven et al. [4] but also previously with single-stranded M13 phage containing a site-directed abasic site [8] . Given that SOS induction increases the survival of the damaged phage by promoting translesion synthesis, it is a matter of simple arithmetic to calculate from the data in these papers whether SOS-mediated translesion synthesis at abasic sites results in any change in the number of surviving phages with frameshift mutations. The bottom line of that sum is that SOS translesion synthesis, while greatly increasing the number of viable phages with base substitution mutations, has little or no effect on the number of viable phages with frameshifts, making it hard to sustain the contention of Reuven et al. [4] that the role of Umu proteins is to divert translesion synthesis from a frameshift to a base-pair substitution pathway.
Do the results so far lead to a better understanding of the mechanism of SOS mutagenesis? What about the suggestion that Umu proteins cause polymerase III holoenzyme to override its normally high specificity? Tang et al. [3] found that, in vitro, polymerase II can function in translesion synthesis in addition to polymerase III holoenzyme. This must surely make it less likely that Umu proteins interact directly with the polymerase. UmuD′ 2 C is known to form a complex with RecA and to bind to single-stranded DNA. It seems likely that, in doing so, an environment is created in which either polymerase III holoenzyme or polymerase II can operate less stringently (see Figure 1) .
Of the two operational steps in translesion synthesis, everything points to the UmuD′ 2 C complex as being particularly important in the second, elongation step (bypass). Whether it does this by encouraging the polymerase, or whether it has an intrinsic ability to insert a base onto a 3′ mismatch end, acting perhaps as a terminal nucleotidyl transferase, is still in question. Current models favour the former, but the alternative has not so far been excluded and must now surely be amenable to in vitro experimentation. Genetic studies have suggested that the first step, in Elongation continues with an increased probability of errors before the UmuD' 2 C and polymerase III fall off which nucleotides are inserted opposite damaged bases, can be carried out without the involvement of Umu proteins. This is confirmed by several in vitro studies in which dNTP cycling has been demonstrated when a polymerase idles opposite a blocking lesion, alternately inserting and then removing nucleotides. It should now be possible to approach these questions biochemically using the in vitro system. Although DNA damage is the best-studied inducer of the SOS mutagenesis system, and translesion synthesis is the best-studied consequence, the SOS system can be induced in other ways, for example in aging colonies [1] , and not all the mutations that are generated arise from translesion synthesis. Thus, under the influence of UmuD, UmuC, RecA and Ssb, the DNA polymerase III complex is not processive and tends to fall off the DNA. Before doing so, however, it makes insertions at undamaged sites [3] , an observation consistent with genetic evidence that SOS-induced bacteria are also mutators for undamaged DNA. These 'untargeted' mutations must contribute to the overall mutagenic effect and support the view -still a matter of controversy -that the prime purpose of SOS mutagenesis is the generation of genetic variability, rather than survival from DNA damage, useful though this may be to the individual cell. Perhaps the 'cost' of getting past a lesion is actually the prime objective, after all!
